Literature DB >> 35422389

RNA Polymerases I and III in development and disease.

Kristin En Watt1, Julia Macintosh2, Geneviève Bernard3, Paul A Trainor4.   

Abstract

Ribosomes are macromolecular machines that are globally required for the translation of all proteins in all cells. Ribosome biogenesis, which is essential for cell growth, proliferation and survival, commences with transcription of a variety of RNAs by RNA Polymerases I and III. RNA Polymerase I (Pol I) transcribes ribosomal RNA (rRNA), while RNA Polymerase III (Pol III) transcribes 5S ribosomal RNA and transfer RNAs (tRNA) in addition to a wide variety of small non-coding RNAs. Interestingly, despite their global importance, disruptions in Pol I and Pol III function result in tissue-specific developmental disorders, with craniofacial anomalies and leukodystrophy/neurodegenerative disease being among the most prevalent. Furthermore, pathogenic variants in genes encoding subunits shared between Pol I and Pol III give rise to distinct syndromes depending on whether Pol I or Pol III function is disrupted. In this review, we discuss the global roles of Pol I and III transcription, the consequences of disruptions in Pol I and III transcription, disorders arising from pathogenic variants in Pol I and Pol III subunits, and mechanisms underpinning their tissue-specific phenotypes.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  POLR3-related leukodystrophy; RNA Polymerase I; RNA Polymerase III; Ribosome biogenesis; Treacher Collins syndrome; rRNA

Year:  2022        PMID: 35422389      PMCID: PMC9550887          DOI: 10.1016/j.semcdb.2022.03.027

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.499


  248 in total

Review 1.  Neural crest specification: migrating into genomics.

Authors:  Laura S Gammill; Marianne Bronner-Fraser
Journal:  Nat Rev Neurosci       Date:  2003-10       Impact factor: 34.870

2.  Primary structure, neural-specific expression, and dendritic location of human BC200 RNA.

Authors:  H Tiedge; W Chen; J Brosius
Journal:  J Neurosci       Date:  1993-06       Impact factor: 6.167

3.  POLR3A variants in striatal involvement without diffuse hypomyelination.

Authors:  Takuya Hiraide; Kazuo Kubota; Yu Kono; Seiji Watanabe; Tomoko Matsubayashi; Mitsuko Nakashima; Tadashi Kaname; Toshiyuki Fukao; Nobuyuki Shimozawa; Tsutomu Ogata; Hirotomo Saitsu
Journal:  Brain Dev       Date:  2020-01-10       Impact factor: 1.961

Review 4.  The nucleolus: an emerging target for cancer therapy.

Authors:  Nadine Hein; Katherine M Hannan; Amee J George; Elaine Sanij; Ross D Hannan
Journal:  Trends Mol Med       Date:  2013-08-15       Impact factor: 11.951

Review 5.  Ribosomopathies: There's strength in numbers.

Authors:  Eric W Mills; Rachel Green
Journal:  Science       Date:  2017-11-03       Impact factor: 47.728

6.  Ataxia, delayed dentition and hypomyelination: a novel leukoencephalopathy.

Authors:  N I Wolf; I Harting; A M Innes; S Patzer; P Zeitler; A Schneider; A Wolff; K Baier; J Zschocke; F Ebinger; E Boltshauser; D Rating
Journal:  Neuropediatrics       Date:  2007-04       Impact factor: 1.947

7.  Mammalian neurogenesis requires Treacle-Plk1 for precise control of spindle orientation, mitotic progression, and maintenance of neural progenitor cells.

Authors:  Daisuke Sakai; Jill Dixon; Michael J Dixon; Paul A Trainor
Journal:  PLoS Genet       Date:  2012-03-29       Impact factor: 5.917

8.  Endocrine Aspects of 4H Leukodystrophy: A Case Report and Review of the Literature.

Authors:  Emma Billington; Geneviève Bernard; William Gibson; Bernard Corenblum
Journal:  Case Rep Endocrinol       Date:  2015-05-31

9.  BRF1 mutations alter RNA polymerase III-dependent transcription and cause neurodevelopmental anomalies.

Authors:  Guntram Borck; Friederike Hög; Maria Lisa Dentici; Perciliz L Tan; Nadine Sowada; Ana Medeira; Lucie Gueneau; Holger Thiele; Maria Kousi; Francesca Lepri; Larissa Wenzeck; Ian Blumenthal; Antonio Radicioni; Tito Livio Schwarzenberg; Barbara Mandriani; Rita Fischetto; Deborah J Morris-Rosendahl; Janine Altmüller; Alexandre Reymond; Peter Nürnberg; Giuseppe Merla; Bruno Dallapiccola; Nicholas Katsanis; Patrick Cramer; Christian Kubisch
Journal:  Genome Res       Date:  2015-01-05       Impact factor: 9.043

10.  Dystonia in RNA Polymerase III-Related Leukodystrophy.

Authors:  Ghalia Al Yazidi; Luan T Tran; Kether Guerrero; Adeline Vanderver; Raphael Schiffmann; Nicole I Wolf; Sylvain Chouinard; Geneviève Bernard
Journal:  Mov Disord Clin Pract       Date:  2019-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.